“Therapeutic Approach With PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes”. 2020. Cardiology and Cardiovascular Medicine 4 (6): 736-42. https://fortunejournals.org/ojs/index.php/ccm/article/view/15983.